Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-11-17 00:00:00 ET · period of report 2021-11-15 · accession 0001708138-21-000085 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-17 | 2021-11-15 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $270.43 | +25.0K | 51.9K | +93% | +$6.76M |
| D | 2021-11-17 | 2021-11-15 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $641.50 | -18.2K | 33.7K | -35% | -$11.69M |
| DM | 2021-11-17 | 2021-11-16 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | S - Sale+OE | $656.86 | -6,778 | 30.7K | -18% | -$4.45M |
| D | 2021-11-17 | 2021-11-15 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $0.00 | -25.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-15 | M | A | 25,000 | $270.43 | 51,931 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-15 | F | D | 18,222 | $641.50 | 33,709 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-16 | S | D | 528 | $652.20 | 33,181 | D | — | — | (F1) Represents volume-weighted average price of sales of 528 shares of Company stock on November 16, 2021 at prices ranging from $652.01 to $652.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 4 | Common | Common Stock | 2021-11-16 | S | D | 840 | $653.41 | 32,341 | D | — | — | (F2) Represents volume-weighted average price of sales of 840 shares of Company stock on November 16, 2021 at prices ranging from $653.03 to $653.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 5 | Common | Common Stock | 2021-11-16 | S | D | 1,260 | $654.33 | 31,081 | D | — | — | (F3) Represents volume-weighted average price of sales of 1,260 shares of Company stock on November 16, 2021 at prices ranging from $654.03 to $654.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 6 | Common | Common Stock | 2021-11-16 | S | D | 500 | $660.51 | 26,931 | D | — | — | (F8) Represents volume-weighted average price of sales of 500 shares of Company stock on November 16, 2021 at prices ranging from $660.33 to $660.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 7 | Common | Common Stock | 2021-11-16 | S | D | 2,403 | $659.42 | 27,431 | D | — | — | (F7) Represents volume-weighted average price of sales of 2,403 shares of Company stock on November 16, 2021 at prices ranging from $659.01 to $659.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 8 | Common | Common Stock | 2021-11-16 | S | D | 697 | $658.50 | 29,834 | D | — | — | (F6) Represents volume-weighted average price of sales of 697 shares of Company stock on November 16, 2021 at prices ranging from $658.03 to $658.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 9 | Common | Common Stock | 2021-11-16 | S | D | 200 | $657.18 | 30,531 | D | — | — | (F5) Represents volume-weighted average price of sales of 200 shares of Company stock on November 16, 2021 at prices ranging from $657.09 to $657.34. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 10 | Common | Common Stock | 2021-11-16 | S | D | 350 | $655.03 | 30,731 | D | — | — | (F4) Represents volume-weighted average price of sales of 350 shares of Company stock on November 16, 2021 at prices ranging from $655.01 to $655.07. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 11 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-11-15 | M | D | 25,000 | $0.00 | 0 | D | $270.43 · — to 2023-12-13 | 25,000 Common Stock | (F9) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |